All news from Anaesthesiology

Improved Recurrence Rates After Lumpectomy

Due to multimodal breast cancer therapies, 5-year local recurrence rates following lumpectomy have dropped significantly, making breast-conserving surgery (BCS) an option for more patients with breast cancer, say researchers.

Effectiveness of Lapatinib against Breast Cancer

The breast cancer drug lapatinib which is designed to shrink tumors can sometimes cause them to grow in the lab, according to a new study published in eLife. By understanding the molecular basis of this phenomenon, scientists hope that their findings will lead to safer treatment decision-making and drug design in the future.

Health Insurance in Nepal

Every citizen shall have the right to get basic health care and have equal access to health services. These are the fundamental rights guaranteed in the Constitution of Nepal. Besides, Nepal aims to fulfill its commitment of achieving Goal 3 of the United Nations Sustainable Development Goals, which is ensuring good health and well-being of the people by 2030.

Management of Pulmonary Hydatid Cysts

In this article, researchers report a series of cases of solitary pulmonary hydatid cyst managed with a new minimally invasive technique using video-assisted thoracoscopic surgery with mini-thoracotomy in order to prevent spillage and facilitate management of the residual cavity and control of the associated bronchial fistulas.

AYUSH: Effects of Ayurvedic Medicines Probed

In another push for Ayurveda, a combined research by the Directorate of Ayurveda and Indian Council of Medical Research (ICMR) is probing the effects of ayurvedic medicines in the treatment of osteoporosis in women over 40 years of age.

About 1,000 women have been screened in the bone health clinic of the National Institute of Research in Reproductive Health (NIRRH) in Naigaon. Of these, 200 women were diagnosed with osteoporosis. The Ayurvedic treatment, comprising Mukta Shukti medicine, will be undertaken for three months on these women.

RBC transfusion Compatibility Improved With Gene Editing

The provision of blood for patients who require repeated blood transfusions, as well as for individuals with rare blood types, presents an enormous challenge to transfusion services worldwide.

While most people can safely receive a blood transfusion from donated blood, patients with blood disorders such as thalassemia or sickle cell disease require frequent transfusions.

With repeated transfusion, patients eventually develop an immune response to all but the most specifically matched donor blood due to incompatibility at the level of minor blood group antigens. The study has been published in EMBO Molecular Medicine.